Anna Syreeni

10PUBLICATIONS
44CO-AUTHORS
Major global burdens of diseaseBehavioural epidemiologyEpigenetics (incl. genome methylation and epigenomics)NeurogeneticsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 24, 2026
Long-Term Impact of Cumulative Hyperglycaemia on DNA Methylation and its Role in Diabetic Kidney Disease.

|Oct 20, 2026
Accelerated Epigenetic Ageing in Diabetic Kidney Disease: A Comparison of 10 Epigenetic Clock Measures in Individuals With Type 1 Diabetes.

|Jan 22, 2026
Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes.

Anna Syreeni, Emma H Dahlström, Laura J Smyth

|Dec 09, 2024
Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes.

Anna Syreeni, Emma H Dahlström, Laura J Smyth

|Aug 05, 2024
Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease.

Jani K Haukka, Anni A Antikainen, Erkka Valo

|May 22, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes.

Zhuo Chen, Eiichiro Satake, Marcus G Pezzolesi

Pageof 2

Frequent Collaborators

10 joint publications

Niina Sandholm

9 joint publications

Per-Henrik Groop

7 joint publications

Emma H Dahlström

5 joint publications

Amy Jayne McKnight